Clinical trial
Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children
NCT00055107 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00055107 |
|---|---|
| Title | Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children |
| Official title | A Phase I/II Open Label Study of Nitazoxanide (NTZ) for the Treatment of Cryptosporidium Parvum in HIV Infected Infants, Children, and Adolescents |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Cryptosporidiosis |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| Enrollment | 6 |
| Completion | May 1, 2006 |
| First posted | Feb 20, 2003 |
| Last update posted | Nov 1, 2021 |
| Countries | South Africa, Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: